|
|
Previous Article | Table of Contents | Next Article 
Decreased concentrations of tumor necrosis factor-alpha in supernatants of
monocytes from homozygotes for hereditary hemochromatosis
VR Gordeuk, S Ballou, G Lozanski and GM Brittenham
Department of Medicine, MetroHealth Medical Center, Case Western Reserve
University School of Medicine, Cleveland, OH 44109.
To determine whether release of tumor necrosis factor-alpha (TNF- alpha), a
cytokine that affects iron homeostasis, may be selectively altered in
hereditary hemochromatosis, we measured concentrations of TNF-alpha and
interleukin-1 beta (IL-1 beta) in supernatants of cultured peripheral blood
monocytes from 11 homozygotes for hereditary hemochromatosis, 11 healthy
individuals, and five patients with iron- loading anemia. The gene for
hereditary hemochromatosis is tightly linked to the HLA locus on chromosome
6, but its exact site and product are not known. The gene for TNF-alpha
also is located within the HLA region. Monocytes were incubated from 4 to
36 hours in medium alone or with added lipopolysaccharide. Mean
concentrations of immunoreactive TNF-alpha in supernatants were
significantly lower for subjects with hereditary hemochromatosis as
compared to healthy controls (P less than .037) and patients with
iron-loading anemia (P less than .005); differences between homozygotes for
hemochromatosis and healthy controls were up to 4.5-fold at 4 hours (P =
.008), 1.9-fold at 12 hours (P = .036), and 7.0-fold at 36 hours (P =
.001). Importantly, concentrations of IL-1 beta in supernatants were not
significantly different among the three groups. We conclude that release of
TNF-alpha by monocytes may be selectively impaired in hereditary
hemochromatosis. Deficient activity of TNF-alpha may contribute to the
disordered iron metabolism of this disease.
Volume 79,
Issue 7,
pp. 1855-1860,
04/01/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Wang, E. E. Johnson, H. N. Shi, W. A. Walker, M. Wessling-Resnick, and B. J. Cherayil
Attenuated Inflammatory Responses in Hemochromatosis Reveal a Role for Iron in the Regulation of Macrophage Cytokine Translation
J. Immunol.,
August 15, 2008;
181(4):
2723 - 2731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wullaert, G. van Loo, K. Heyninck, and R. Beyaert
Hepatic Tumor Necrosis Factor Signaling and Nuclear Factor-{kappa}B: Effects on Liver Homeostasis and Beyond
Endocr. Rev.,
June 1, 2007;
28(4):
365 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Olakanmi, L. S. Schlesinger, and B. E. Britigan
Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages
J. Leukoc. Biol.,
January 1, 2007;
81(1):
195 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-A. Krayenbuehl, F. E. Maly, M. Hersberger, P. Wiesli, A. Himmelmann, K. Eid, P. Greminger, W. Vetter, and G. Schulthess
Tumor Necrosis Factor-{alpha} -308G>A Allelic Variant Modulates Iron Accumulation in Patients with Hereditary Hemochromatosis
Clin. Chem.,
August 1, 2006;
52(8):
1552 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fargion, L. Valenti, P. Dongiovanni, A. Scaccabarozzi, A. L. Fracanzani, E. Taioli, M. Mattioli, M. Sampietro, and G. Fiorelli
Tumor necrosis factor {alpha} promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis
Blood,
June 15, 2001;
97(12):
3707 - 3712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Distante, J P Berg, K Lande, E Haug, and H Bell
HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis
Gut,
October 1, 2000;
47(4):
575 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Brittenham, G. Weiss, P. Brissot, F. Laine, A. Guillygomarc'h, D. Guyader, R. Moirand, and Y. Deugnier
Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism
Hematology,
January 1, 2000;
2000(1):
39 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Mulero and J. H. Brock
Regulation of Iron Metabolism in Murine J774 Macrophages: Role of Nitric Oxide-Dependent and -Independent Pathways Following Activation With Gamma Interferon and Lipopolysaccharide
Blood,
October 1, 1999;
94(7):
2383 - 2389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Moura, M. A. Noordermeer, N. Verhoeven, A. F.M. Verheul, and J. J.M. Marx
Iron Release From Human Monocytes After Erythrophagocytosis In Vitro: An Investigation in Normal Subjects and Hereditary Hemochromatosis Patients
Blood,
October 1, 1998;
92(7):
2511 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Recalcati, R. Pometta, S. Levi, D. Conte, and G. Cairo
Response of Monocyte Iron Regulatory Protein Activity to Inflammation: Abnormal Behavior in Genetic Hemochromatosis
Blood,
April 1, 1998;
91(7):
2565 - 2572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cairo, S. Recalcati, G. Montosi, E. Castrusini, D. Conte, and A. Pietrangelo
Inappropriately High Iron Regulatory Protein Activity in Monocytes of Patients With Genetic Hemochromatosis
Blood,
April 1, 1997;
89(7):
2546 - 2553.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|